Profile
Jocelyn Olive Joined FOndations Capital in 2008, as an Investment Manager.
He was previously an Associate with L Capital, a private equity fund sponsored by the LVMH Group, which he joined in 2005 and where he was involved with several mid-cap buyout transactions in France and neighboring countries, with a focus on retail and consumer goods segments.
Prior to joining L Capital, Jocelyn worked as a consultant with Bird Consulting, where he focused on strategic turnaround situations and corporate finance operations.
Jocelyn is a graduate from the Ecole Supérieure des Sciences Economiques et Commerciales (ESSEC) in Paris and has a law degree from Université of Cergy-Pontoise.
Jocelyn Olive active positions
| Companies | Position | Start |
|---|---|---|
BioRéalités SAS
 BioRéalités SAS Pharmaceuticals: MajorHealth Technology BioRéalités develops novel therapeutic and diagnostic tools to improve the life of colorectal cancer patients. The company was created as an SAS in february 2007, and has been furthering the work of its founders in the field of oncology, with a particular focus on the characterization of a novel target for colorectal cancer therapy. BioRéalités currently employs 13 staff and recently moved in their own facility, which include a 200 m2 laboratory area. The company has been granted an exclusive international license to exploit a PCT patent lodged by INSERM, CNRS, and the University of Montpellier 1 in 2006. | Director/Board Member | 03/05/2010 |
Former positions of Jocelyn Olive
| Companies | Position | End |
|---|---|---|
Fondations Capital Services France SASU
 Fondations Capital Services France SASU Investment ManagersFinance Fondations Capital Services France SASU (FCSF) is an independent private equity firm headquartered in Paris, France. The firm was founded in 2007 by Xavier Marin and Philippe Renauld. | Private Equity Analyst | 01/03/2012 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
BioRéalités SAS
BioRéalités SAS Pharmaceuticals: MajorHealth Technology BioRéalités develops novel therapeutic and diagnostic tools to improve the life of colorectal cancer patients. The company was created as an SAS in february 2007, and has been furthering the work of its founders in the field of oncology, with a particular focus on the characterization of a novel target for colorectal cancer therapy. BioRéalités currently employs 13 staff and recently moved in their own facility, which include a 200 m2 laboratory area. The company has been granted an exclusive international license to exploit a PCT patent lodged by INSERM, CNRS, and the University of Montpellier 1 in 2006. | Health Technology |
Fondations Capital Services France SASU
Fondations Capital Services France SASU Investment ManagersFinance Fondations Capital Services France SASU (FCSF) is an independent private equity firm headquartered in Paris, France. The firm was founded in 2007 by Xavier Marin and Philippe Renauld. | Finance |
- Stock Market
- Insiders
- Jocelyn Olive
